Media Inquiries

Beth Calitri

Corporate Communications, Media Relations

978.417.2031

[email protected]
Sort by Year
February 13, 2012

Ironwood Pharmaceuticals Announces Exercise of Over-Allotment Option in Public Offering of Common Stock

February 9, 2012

Ironwood Pharmaceuticals Prices Public Offering of Common Stock

February 8, 2012

Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock

February 8, 2012

Ironwood Announces FDA Advisory Committee Meeting Will Not Be Scheduled in Connection with New Drug Application for Linaclotide

January 4, 2012

Ironwood Pharmaceuticals and Bionomics Announce Collaboration, Research, and License Agreement

January 3, 2012

Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

November 7, 2011

Ironwood Pharmaceuticals Provides Third Quarter 2011 Investor Update

November 2, 2011

Ironwood Pharmaceuticals to Present at Credit Suisse 2011 Healthcare Conference

October 31, 2011

Ironwood Pharmaceuticals to Host Third Quarter 2011 Investor Update Call

October 27, 2011

Ironwood and Forest to Present Linaclotide Results from Phase 2B and Phase 3 Trials in Patients with Irritable Bowel Syndrome with Constipation or Chronic Constipation

October 24, 2011

Ironwood and Forest Announce Linaclotide New Drug Application for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Constipation Accepted for FDA Review

September 29, 2011

Ironwood Announces Linaclotide European Regulatory Submission for the Treatment of Irritable Bowel Syndrome with Constipation

September 21, 2011

Ironwood Pharmaceuticals to Present at Jefferies 2011 Global Healthcare Conference

September 6, 2011

Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference

August 11, 2011

Ironwood Pharmaceuticals Provides Second Quarter 2011 Investor Update

Copyright © 2021, Ironwood Pharmaceuticals, Inc. All Rights Reserved

LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.